PROCESS FOR PREPARING TEST ELEMENTS

Abstract: The invention relates to a process for making a test element, such as an analytical test element. Compositions of matter, such as analyte specific receptors, are treated to carry a charge. These are then applied to test carriers treated to carry a charge opposite that of the composition of matter. Interaction of charge fixes the composition of matter to the test element.

Description: PROCESS FOR PREPARING TEST ELEMENTS FIELD OF THE INVENTION This invention relates to the field of clinical diagnosis. More particularly, it relates to dry chemistry based analytical devices, processes for manufacturing these, as well as their use. BACKGROUND AND PRIOR ART Clinical diagnosis relates, in general, to the determination and measurement of various substances which relate to the health or general status of an individual. Physicians, health care workers, and the general public as well are concerned about the presence and levels of various substances in body fluids such as blood, urine, and so forth. Among the substances which have been measured in clinical analysis for a long time are glucose, cholesterol, and various enzymes such as amylase and creatine kinase. More recently, determinations as to pregnancy, blood disorders ("Quick's" tests, Partial thro blastin time or "Ptt" tests, etc.) , and infections have also become routine in clinical diagnosis. Of most pressing concern to the field, e.g. , is the determination of antibodies to human immunodeficiency virus (HIV) , as a marker for Acquired Immune Deficiency Syndrome ("AIDS") or Aids Related Complex ("ARC") . The new tests for this virus, however, build on a broad and deep base of earlier advances in the field. An oversimplification which nonetheless serves to place the subject invention in proper context is division of the field into "wet chemistry" and "dry chemistry" . The former pertains to methodologies where a reaction takes place completely in a liquid state. Exemplary of such chemistries is U.S. Patent No. 4,818,692, which describes an alpha amylase assay. Review of this reference shows that a reagent is added to a liquid sample, and, if the analyte of interest (amylase) is present, the reagent reacts with it, yielding a color. The development and intensity of the color are monitored as a determination of the presence and amount of the analyte ("Analyte" as used hereafter, in any context, refers to a substance to be determined). "Dry chemistry", in contrast, involves the placement of some or all of the reagents which are involved in determination of an analyte under consideration onto a solid material, such as a paper strip. The sample is brought into contact with the solid material, and some or all of the reactions which are necessary for the detection of the analyte in question take place ii situ. If additional reactions involving reagents not found on the solid material are required, these can be added after the preliminary reactions take place. The invention concerns dry chemistry, and therefor wet chemistry is not discussed hereafter. The art is filled with many different examples of dry chemistry apparatus used for clinical analysis. Examples of some of the patents in the field include U.S. Patent No. 4,446,232, to Liotta, 4,361,537 to Deutsch et al., and 4,861,711 to Friesen et al. Liotta teaches a very simple example of a zoned test strip useful in immunodiagnostics. A support such as a paper strip, has enzyme linked antibodies positioned in the strip, as well as a reagent which can react with the enzyme label. When analyte for which the antibody is specific is contacted to the strip, the antibodies bind with the analyte and diffuse to the point in the strip where the substrate reagent is found. There, enzyme-substrate interactions take place resulting in a color forming reaction, indicating the presence of analyte in the sample. If analyte is not present, then the conjugate is immobilized in the "solid phase" zone, preventing interaction of enzyme and substrate. The Deutsch patent teaches a test strip which is contained in what is essentially a capped test tube. The test strip has various reagents positioned along its length. When liquid iε introduced at one end of the strip, it moves via capillarity up the strip, and various reactions take place along it. Friesen et al. teaches several zoned devices in which different forms of im unological reactions, such as competitive and sandwich immunoassays can take place. These three patents show the general efficacy of test strips based upon fibrous materials, such as paper, in various forms of diagnostics. Many other patents show similar teachings, including U.S. Patent Nos. 3,888,629 (Bagshawe) , 4,366,241 (Tom et al.) 4,517,288 (Giegel et al.), 4,668,619 (Greenquist et al.) , 4,708,932 (Axen et al.) , 4,774,174 (Giegel et al.) 4,786,606 (Giegel et al.), 4,824,640 (Hildebrand et al.) , and 4,855,240 (Rosenstein et al.). All of these patents show the general applicability of solid test strips for clinical analysis. Tom et al. , for example, at columns 19-26, which are incorporated by reference herein, gives a roster of some of the various analytes which may be assayed by using dry chemistry. Dry chemistry is also taught in connection with the analysis of specific analytes, such as cholesterol (U.S. Patent No. 3,983,005, to Goodhue et al.), human chorionic gonadotropin (U.S. Patent No. 4,496,654 to Katz et al.), hemoglobin (U.S. Patent No. 4,742,002, to Guadagno) , and blood type antigens (U.S. Patent No. 4,851,210, to Hewett) . While analytical test strips of the type described supra are popular, they are not without their problems. Strips made of bibulous materials such as paper, e.g., are subject to wide fluctuations in the quality and properties of the materials used. In addition, impregnation or placement of reagents, such as antibodies on the strip may require processes which lead to degradation of the reagent. For example, if a protein reagent is applied to a test strip in a liquid form, it must of course be dried. Drying may require heat, however, and heat is one of the most notorious inactivators of proteins. Further, due to the inherent absorptive nature of bibulous materials such as paper, it is difficult, if not impossible, to control the eventual distribution of the reagents on the strips when one is attempting to incorporate reagents in a predefined, prescribed, or preferred fashion. Even when extremely stringent criteria of quality control are used, since the capillarity of paper, e.g., can vary not only from strip to strip but even within a single strip, preparation of a strip always carries a risk. Additionally, fibrous materials are not inert. When assaying for an analyte, it usually happens that a certain amount of it will adhere to the fibers of the strip rather than to reactants, such as antibodies placed on the strip. As a result, interpreting a particular test strip can be very difficult. Given the concerns set out supra, as well as others which are not repeated here but are well known to the art, there have been attempts to use other materials. Different fibrous and gel or film materials have been used as supports, but these are not altogether satisfactory for many of the reasons set forth herein. Attention has therefore turned to other materials, including particulate matter such as beads or spheres made of "inert" materials. "Inert" as used herein simply means that the material does not interfere with reactions which are involved in the clinical application under consideration. To say that there are many patents relating to the use of inert particles in clinical and immunological assays is to understate the case. A sampling of some of the U.S. Patents in this area include 4,794,090 (Parha et al.), 4,740,468 (Weng et al.), 4,680,274 (Sakai et al.), 4,657,739 (Yasuda et al.), 4,478,946 (VanderMerwe et al.), 4,438,239 (Rembaum et al.) , 4,340,564 (Harte et al.), 4,338,094 (Elahi) , 4,201,763 (Monthony et al.), 4,166,102 (Johnson) and 4,059,658 (Johnson) . The vast majority of the literature relating to the use of "active" or "loaded" particles, however, is not at all pertinent to this invention. In general, particulate material is used in wet chemistry systems, such as agglutination assays, along the lines of those described supra. A solution containing particles having receptors, such as antibodies bound thereto, is added to a sample being analyzed. If the analyte in question is present in the sample, it binds to the receptor which is itself bound to the particle. As a result of the binding, the particles agglutinate for any of a number of different reasons. Such applications of particle technology are not pertinent to this invention. Microparticles present both advantages and disadvantages when used in preparation of analytical devices. The advantages include the uniform size. Also, they increase surface area on which reactions can take place without a need for increased sample volumes. As a result, the speed of reaction can increase. Disadvantages include the possibility of undesirable uncontrolled aggregation of the beads. Also, non specific binding can result in false reactions. When particles are placed in fibrous matrices, they can move, thus confusing results via a "blurring" effect. Somewhat more pertinent to this invention are apparatus where particulate material carrying, e.g., a receptor, is contained in a carrier, such as a test strip. The patents to Weng et al. and Yasuda et al. are exemplary of such systems. The problem with the use of particles, such as beads in porous carriers, however, is that the particles, left to themselves, can move in the fibrous matrix, not unlike a ball or marble rolling on a carpet. This tendency to move is exacerbated when a flowing material, such as a liquid, is added to the matrix. The particles then move throughout the device and even off of it with the moving solution front, rendering the test strip useless. A different approach to the field of clinical diagnosis attempts to avoid these problems by not using fibrous matrices at all or using fiber in a separate layer, such an approach iε exemplified by, e.g., U.S. Patent No. 4,258,001, to Pierce. This patent teaches a dual layer system, where one layer " is a structure made of particles bound together by an adhesive. The patent describes the particles as poεεibly containing a so-called "interactive composition" such as an antigen or antibody. This layer is positioned on a support. Analyte containing liquid passes through the porous particle layer, and the analyte reacts with the interactive composition. A system along the lines of that described by Pierce, however, is not without its problems. Adhesives, by their nature, are sticky. Even when dried, a certain amount of "tack" iε present which, although small, may not be insignificant with respect to sample analyte. Aε a result, false binding to adhesive, rather than to the "interactive composition" may occur. In addition, there iε some difficulty in the manufacture of uniform arrayε of adhered beadε, because distribution of the beads may not be uniform, and the drying of adhesive may occur at different rates, depending on parameters, such as thickness of the array. Recently, the art has seen some approaches to this problem. U.S. Patent No. 4,916,056, to Brown, III et al., suggeεtε that by selecting an appropriate fibrous matrix and particles of a particular size, one can immobilize the latter in the former. At column 8, lines 60-65 the inventors concede that the reason for this is not known, and review of the disclosure in its entirety gives no information as to any treatment applied to the particles. European Patent Application Number 200 381 alεo teaches the use of beads with antibodies bound to them in a matrix; however, this disclosure states, while the beads are trapped within the matrix, they are nonethelesε mobile. Such a teεt εtrip is not completely satisfactory for use in clinical assays. One of the consequences of advances in fields related to clinical chemistry, such as immunology, is that many applicationε of the field which were once deemed sophisticated have now become quite commonplace. One result of this development has been the creation of a home diagnostic market, i.e., a subfield of clinical chemistry in which an individual performs an aεεay at home, rather than having a health profeεsional perform it. The home user is not trained in the interpretation of clinical parameters, and as such home diagnoεtic productε are generally reεtricted either to εystems where a "yes/no" type of test is used, or one where an unambiguous answer is provided by the test apparatuε used. The patent literature shows examples of devices useful in home diagnostics in Brown III et al., U.S. Patent No. 4,916,056, discussed above, and in Valkirs et al., U.S. Patent No. 4,632,901. Both disclosureε are drawn in particular to self diagnosis of pregnancy, and point to the need in such systems for an adequate negative control. Indeed, the art has long recognized the desirability and necessity for "on-board" controls in test εtrips. Examples of disclosureε teaching these are 4,649,121 (Ismail et al.), 4,558,013 (Markinovich et al.), 4,541,987 (Guadagno), 4,540,659 (Litman et al.), 4,472,353 (Moore), and 4,099,886 (Olveira) . The use of controls on many of these devices shows that they are useful for the skilled practitioner aε well aε for the home user. The art shows that both "negative" and "positive" controls are used. A "negative" test is one which will inform the user that the test sample does not contain the analyte of interest. In contrast, a true negative "control", as the phrase is used herein, should never give a signal if reagents are operating properly. Thiε iε true regardless of whether or not the analyte of interest iε present. A positive control essentially tells the user that the system and device are functional. Such controls may contain samples of the analyte of interest and the reagent components which are essential to the reaction which must take place to identify analyte in a test εample. Positive controls should always generate a signal when an analytical device containing one iε uεed. If a signal is not generated, then the user has an indication that the apparatus iε no longer functional. Thuε, poεitive controlε can serve to "date" a test εtrip by checking the εystem or reagent integrity. They can alεo indicate when a test εtrip or other εystem component haε been stored improperly, or where quality control has not been adequate. Given continued growth in the diagnostic market, positive controls loom as being more and more important. As haε been indicated supra, among the εtresseε to which analytical apparatuεeε are εubjected are long periodε of εtorage. Otherε include improper uεe or negligent handling. Such stresses may jeopardize the integrity of the apparatus, and may alεo damage it. It will be clear, of course, that teεt εtripε and other analytical apparatuε should not be exposed to the environment prior to their intended uεe in analyεiε of a εample. Exposure to the environment, e.g., may result in physical harm and/or chemical contamination of the strip. Thus it iε clear that theεe apparatuε are desirably protected until used. The desirability of protecting the strip must be balanced by the coεt of providing it. Given the enormous volume of test stripε uεed by clinical laboratories, physicians offices and so forth, the cost must be kept as low as poεεible. To that end, many of theεe devices are packaged cheaply with, e.g., cellophane or plastic, in the form of bagε, poucheε, etc. Such packaging provideε a certain amount of protection, but εerve no uεeful purpoεe in connection with the uεe of the εtrip. Since many of the teεt stripε in the art are uεed in analyεis of infectious materialε, and in connection with biological εampleε εuch aε blood, urine, sputum, feces, and εo forth, it is desirable that the protection afforded the test strip also serve to minimize contact of the individual using the strip with the sample. Additionally, since it is desirable for theεe stripε to be configured εo that they can be uεed without any εophiεticated knowledge on the part of the uεer, ideally the caεing for the εtrip εhould make it easy for the user to employ the device. Also, the protection or casing structure ideally should be configured to act as a "fail-safe" syεte , if, e.g., too much sample is added to the device. Other desirable features of such a casing include viewing ports or "windows" as well as fluid reservoirs, both of which are described infra. While the art does show the use of test strip holders and casings which move in the direction of the above cited goals, none of these achieve all of them. Examples of caεingε or holderε for test εtrips are εeen in, e.g., U.S. Patent Noε. 4,900,663 (Wie et al.) , 4,851,210 (Hewett) and 4,331,650 (Brewer et al.) , which show the less sturdy type of holder described supra. Frequently these devices are referred to as "test cards", given the nature of their configuration. More substantial holders may be seen in GB 2204398 EP 306 772, EP 323605, EP 306336 and EP 183442. None of these devices posεeεs all of the desired properties, e.g., protection, low cost, and ease of use. To summarize the art, there are approaches to test strip design which utilize bibulous paper and/or particle technologies. Each of these has advantages and/or problems. The prior art teaches the use of controls, both "positive" and "negative" for uεe in diagnostic assays. Different types of configurations are available, but a test strip which incorporates a positive control, a negative control, and a teεting area is not seen in the art. Test strips and devices of the type described herein are frequently enclosed in a caεing or houεing. These structureε permit the actual εtrip to be uεed in a manner that ensures optimal resultε. Such caεing or houεingε εhould be "inert", i.e., they εhould not contain any material which will interfere with the assay or test which is carried out on the test strip. Important aεpects of teεt εtrip houεing include protection of the uεer from the fluid or sample being teεted. Further, the casing must protect the actual εtrip from premature contact with other fluidε. Such "premature" contact can include contact with a fluid that is not being analyzed, as well as the contact of a zone or region within the strip prior to the desired time of contact. Thus, where a set of εequential reactions or reaction steps must take place, the casing or housing can play an important role in regulating these steps. In addition, the type of structure described herein, via appropriate placement of viewing means such as "ports", "windows" or other openings can facilitate the analysiε of a teεt fluid. Also, the housing if constructed in an appropriate manner, will prevent interference with the natural chromatographic nature of the test strip by inappropriate contact with other surfaceε. Other featureε of a houεing or caεing which must be considered include inertness to the asεay. The houεing εhould be made of material which does not interfere with the asεay, reagents, or εample. The housing should also be configured in a way that makes it easy to observe the test, without causing problems such aε the caεting of εhadowε or otherwiεe impeding proper viewing of the reaction. In addition, εince the amount of εample applied to the teεt strip will vary from user to uεer, it is desirable that the holder be configured to prevent overflow or flooding of different sections of the test strip in those situationε where exceεε fluid iε added. Thuε, it iε the purpose of this invention to provide a uεeful analytical apparatus which can be used in determining an analyte in a sample, where the apparatus contains a negative control, a testing area, and a positive control, preferably, but not necessarily, in a linear array of zones placed within a continuous matrix. It is also a purpoεe of the invention to provide a proceεε and methodology uεeful in manufacturing such apparatus, which combines the benefits of both matrix and particle technologies. The discovery of a way in which molecules εuch as proteins, glycoproteins, and other substances can be attached to surfaceε εuch as beads and then to fibers without chemical coupling solveε many of the problemε aεεociated with combining particle and fiber technologieε. It is a further object of the invention to provide a casing or holder for a teεt εtrip which protects the test strip itself, simplifies its uεe by the investigator, and also, surprisingly, helps serves as a fail-safe syεtem to facilitate the take up of εample fluid by the test strip in a controlled manner. How these, aε well aε other aεpects of the invention are achieved will be seen from the discloεure which followε. SUMMARY OF THE INVENTION This invention is based upon several εurprising diεcoverieε, beginning with the obεervation that moleculeε εuch aε, but not limited to proteins, can be εecured to both a εolid carrier and a fiber without the uεe of an adhesive connecting the particles to each other. In fact, thiε iε to be avoided. The molecule of interest is attached to the carrier, preferably via a covalent bond, and is then treated with a solution at a pH different from the isoelectric point (pi) of the molecule attached to the carrier. This treatment impartε a charge to the carrier attached molecule. The matrix, such as a glass fiber matrix, either posεeεεes an inherent charge (in the case of glass fiberε, thiε is negative) , or can be treated to acquire one. By choosing the treatmentε and matriceε so that the carrier bound molecule and matrix have opposing chargeε, the complex can be poεitioned in the matrix, in contrast to devices where an adhered array of particles is positioned on it. The invention encompasseε, inter alia analytical apparatuε with on board poεitive and negative controlε. It haε been found that the force of attraction between the solid carrier bound molecule and the matrix is εo εtrong that exquisitely accurate placement of the carrier/molecule complex on the matrix is possible, without diffusion throughout the porous matrix. Essentially, the carrier stays exactly where it is placed, and as a reεult, the analytical reaction takes place at one and only one position. Due to this desirable result, one can place both positive and negative controlε within the εame apparatus, as there need not be any concern aε to the mixing of reagentε within the εtrip once sample is added thereto. The placement of the carriers throughout the εtrip means that the control and test reactionε will alwayε take place at a particular position on the device. Therefore, one can provide a carrier which is arrayed so that the top preεentε a viewing meanε which specifically indicates where test and control reactions should take place. In addition, because the reagent placement is so well defined, one can be less rigorous about the amount of sample applied to the apparatuε. Thiε can be a concern because if the absorptive capacity of the test strip is exceeded, problems with reagent mingling and washout might result. Thus, the test carrier provided to hold the strip is configured to provide a reservoir for the imbibing of test liquid aε the εtrip can do εo. Theεe main featureε, as well as additional inventive features not deεcribed in thiε Summary, will be explained in greater detail in the text which follows. BRIEF DESCRIPTION OF THE FIGURES Figure 1 displays a broad embodiment of the teεt apparatuε described herein. Figure 2 showε the teεt apparatuε with additional optional featureε. Figure 3a is a top view of the top of an embodiment of the casing for the apparatus. Figure 3b shows a top view of the bottom of a casing for the apparatus. Figure 4 preεentε the reεults of interaction of glass microfiber paper with charged latex, shown using fluorescence. Figure 5 depicts the pH effect with respect to interaction of test carrier and charged material. Figure 6 compareε mobility of treated and untreated particles. Figure 7 presents data obtained in an HIV test strip, where p24 iε receptor. Figure 8 parallels Figure 7, but used gp41 aε receptor DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Referring now to the figures, Figure 1 shows εchematically the analytical apparatuε of the invention in itε broadest embodiment. a teεt εtrip 10 comprises an absorptive matrix 11, composed of material such aε bibulous paper, cellulose, or other material capable of imbibing a liquid sample. The horizontal arrow shows the direction of flow of fluid in the apparatus. Now, referring to the items depicted at "12", "13" and "14" these show a negative control, "read" or "test" region, and positive control, respectively, positioned in a linear array. Each of these regions I, II and III contains reagents described infra. The negative control "I" is designed as a marker for the integrity of the test syεtem. Thiε region or zone εhould never preεent a εignal, εuch aε a color change. For example, if the matrix 11 iε white, bibulouε paper, region 12 should be white both before and after the test analyεiε is carried out. If it is not, then there is something wrong with the apparatus and it should either be destroyed if there is a color present prior to the asεay or the test resultε muεt be diεcarded if a color appears after the test is run. Ideally, this region contains a reagent similar to thoεe uεed in the other zoneε, but one which is non reactive or inert relative to the analyte being examined. For example, if the analyte of interest is an antigen, such as a Streptococcus A antigen which will be detected via an antibody-antigen reaction at "II", the negative control may contain inactivated or non-immune immunoglobulin or antibodies of the same εpecies present in region II. Similarly, if the test in question is one for HIV antibodies where the test region containε viral antigenε, then region I should contain inactive forms of the antigen, such as heat or urea treated material, such that the epitopes to which the antibodies bind are disrupted. Additional materials which can be considered for use in the negative control include inactivated forms of protein A, biotin-streptavidin/avidin complexes, and so forth. Non- immune IgG haε been mentioned, and thiε iε exemplary of non-immunoactive for ε of antibodieε and immunoglobulin in general. Referring to Figure 1, and reference "13" or "II", thiε conεtituteε the test region and iε where the actual analytical assay takes place. This region contains a reagent which will react with the analyte of interest. For example, using the two analytes mentioned supra, if Streptococcus pyrogenes is being asεayed, this region may contain antibodies, polyclonal or monoclonal which specifically bind to Strep A group specific antigen. Antibodies to Strep A are known from the literature, and need not be elaborated upon here. It is to be understood, of course, that "antibodies" refers not only to the complete molecule, but also reactive fragments such as Fab, Fab', Fv and F(ab') 2 fragments and the like. Ideally, but not eεεentially, the reagent iε bound to a solid carrier, as deεcribed infra, and iε placed in the strip such that it is immobile. This placement is also true if one is asεaying for, e.g., HIV antibodies, and in this case the reagent in "II" is, for example, an epitopically active viral protein or fragment of the virus. Many such proteins and fragmentε are known and need not be recited here. In a device uεeful in assaying for HIV or other materials which have many recognized epitopic molecules, a plurality of test zoneε may be positioned in between the positive and negative control. HIV, for example, can be asεayed for by poεitioning test zones containing receptors specific for gpl20, p24, gp41, antibodies to these molecules etc. In a similar fashion, the device may be constructed for "TORCH" testing by positioning of test zones containing receptors which will bind antibodies specific for Toxoplasma, Rubella, Herpes and Cytomegalovirus. The analyte and reagent in II react if the analyte is present in the εample, preferably immobilizing the analyte at zone II. The fluid εample, due to the capillarity of the strip, flow to the third zone III or "14", which iε the poεitive control zone. Thiε zone will contain a εample of the analyte of interest as well as a sample of reagent identical to that deployed in the second zone. As a result, this zone should always evidence a reaction. If it doeε not, then the test is not valid. Thus, the third zone also serves as a functional control for the assay reagents and the strip structure itεelf. In an especially preferred embodiment, once the reactions between sample and the reagents in zones II and III take place, an additional reagent is brought into contact with these zones, so as to result in the formation of a detectable signal, εuch as a color. For example, when strep A is being assayed, following immobilization of the group specific antigen by an antibody at the second zone, a second, labelled antibody is contacted to thiε zone, aε well aε to the third, poεitive zone. Since εome εtrep group antigen moleculeε are multiepitopic, a sandwich of antibody-antigen-labeled antibody can, and does form. The label may inherently posεeεε a εignal, εuch as a radionucleid or chemiluminiscent moiety, colored or fluorescent particles, gold and dye sols or can be one which engages in a further reaction or reactions to generate a signal. Most preferably, theεe labelε are enzymes εuch aε but not limited to peroxidase, alkaline phosphataεe or β-galactosidase. When these labels are used, it is necesεary that additional materials, such as enzyme substrates be added to the stripε. Exampleε, of theεe include tetramethylbenzidine (TMB) , 4-chloro and 4- methoxy-1-naphthol for peroxidaεe catalyzed reactionε and 5-bromo-4-chloro-3-indolyl phoεphate (BCIP) or BCIP and a tetrazolium εalt for alkaline phoεphataεe catalyzed reactionε. Theεe 2 exampleε are by no meanε exhauεtive of the available εubstrates, and the choice of substrate will depend on what is available plus the particular enzyme used. Preferred substrates are those upon which the actions of enzymes yield a product which is insoluble in aqueous media. Both the second labeled antibody and the substrate may be applied to the apparatus from an external source, or can be positioned within the device itself. A second, εupporting layer, e.g. , underneath the teεt zoneε can permit percolation up into the device, or the device can be configured such that subεtrate iε contained in a layer connected to εtructure 10 via a flap means, where thiε layer can only contact the test regions upon application of external force, εuch as pressure. A particularly preferred embodiment of the invention has the subεtrate deployed .in εitu in an optional εtructure. This iε εhown in Figure 2 and iε diεcuεεed infra. The three zones, i.e., negative (21), test (22) and poεitive zoneε (23) , are poεitioned in a linear array relative to each other and εeparated from each other by at least a small amount of space, so that separate and discreet signalε may be generated and determined. If nothing has gone amisε in the manufacture, storage and use of the apparatuε, there are only two possible results. If no analyte of interest is present, zone 21 will give no signal nor will zone 22. In contrast, zone 23 must give one, and the user will note only a single band on the device. In contrast, if analyte is present, both of zones 22 and 23 will give a positive signal, while zone 21 will not. Therefore, in evaluating the sample, it is a simple question of how many bands appear on the surface of the strip. Two bands indicate analyte presence, whereas one band indicates none. As has been explained supra. other considerations as to the validity of the test result are determined from band formation as well. In apparatuε where a multitude of variouε analytes are to be situated and asεayed, such as "TORCH" asεayε deεcribed εupra or aεεayε for different or multiple epitope recognition, εuch aε in HIV determination, a plurality of bandε correεponding to a plurality of teεt zoneε will be preεent, each of which corresponds to a test for a different analyte. In figure 2 a waste zone 24 is added to the end of the strip for absorption of the fluid after it haε traversed zones 21, 22 and 23. The waste zone is preferably constructed of absorptive material which iε at leaεt aε abεorptive as the material out of which matrix 11 is made. On one level thiε feature may be εeen as a convenience rather than a necessity, as other approaches to removing the fluid, such as by contact with an absorbent sponge, may be envisioned. It can be rendered explicitly functional by incorporating therein an agent which allows the use to determine whether the strip haε been exposed to moisture or extremes of acid or base. The art is familiar with substances such as anhydrous copper sulfate, which changes from white to brilliant blue in the presence of liquid, aε well as pH indicators which either change color or form a color when expoεed to acidic or basic conditions. By incorporating these into the waste zone, one can ascertain if the strip has been exposed to undeεirable conditionε prior to uεe. In addition, εuch indicator can also serve as viεual monitors that the strip device is functioning properly with respect to chromatographic flow. While such indicators may be placed anywhere in the device, placement along the waste zone ensures that there is no potential interference with the teεt reactions. In addition, this zone can include so called "signal inhibitors" which prevent reaction of label and reaction partner to generate a signal. Such inhibition is desirable because if such a signal is generated here, "backflow" can carry the signal into the device to a point where it would interfere with the actual reaction signal. Such indicatorε may conveniently be placed in the waεte zone at the poεition identified aε 25 in figure 2. Thiε can alεo be the site for incorporation of an inhibitor for the signal generating system. In such cases an additional "port" or "window" is simply incorporated in the case enclosure to allow for viεualization of indicator reactions. Exampleε of εuch inhibitors include sodium azide, which inhibits, irreverεibly, the action of peroxidaεe. By incorporating the inhibitor in the waste zone, no significant generation of color or other signal in the waste or reεervoir takeε place as the result of interactionε between εignal generating system components. In turn, this helps to preserve test result stability since there is no backwash of color onto the matrix after the asεay has been run. Very desirable features are present in the depicted device at the end opposite the waste zone. Structure 26 compriseε abεorptive material for application of a liquid thereto. Itε role will become clear in connection with components 27-29 shown in figure 2, discuεεed aε followε. Item 27 iε a εtructure, εuch aε a pad which contains a substance or subεtances, such aε the εubεtrateε referred to supra. It is separated from structure 26 over itε forward portion by a piece of double stick tape 28. A second piece of double stick tape 28' separates the substrate pad 27 from flow regulating means 29, which iε in turn in one-way fluid contact with the teεt strip 11. In operation, structures 26-29 come into play, e.g., when a sample haε already been added to the strip and thiε haε been followed by application of a labelled receptor. Exemplary of this situation iε one where a strep antigen has been bound to antibodies on a bead, followed by the binding to the antigen of a second sample of antibodies, containing an enzyme label. In order to determine the binding, nonbound labelled receptor must be washed away and substrate must reach this zone. In order to prevent the need for a εeparate εupply of the substrate reagent, in the embodiment of figure 2 an amount of the substrate iε contained, in removable form, in structure 27, the "subεtrate pad". The εubεtrate cannot be removed until it iε moistened, and to that end adsorptive meanε 26 iε poεitioned above the substrate pad. The moistening agent, or "run buffer" in a preferred embodiment, is applied to 26 at some point along its length and it moves down and into substrate pad. In this way material 26 serves as a "metering" device for delivery of fluid to structure 27. In order to guarantee that the liquid goes only into front end of the subεtrate pad, double εtick tape "28" is provided. This blocks the liquid from going forward, forcing it to move down and into the substrate pad. Additional types of blocking materials may be employed for this purpose, such as hardened hot melt adhesives. In practice, double εtick tape iε preferred. The liquid or run buffer enterε the εubstrate pad and disεolveε/mobilizeε the subεtrate contained therein. Again, to direct the flow of liquid forward, a second block or piece of double εtick tape 28' iε provided. This prevents the liquid from flowing backward. As can be seen in figure 2, this εecond block iε poεitioned at the end of the substrate zone opposite the end where the first block is positioned. In the fashion deεcribed, meanε 28 and 28' are used in combination to establish a predefined-channel for directional fluid flow through component 27. The placement of tape 28' directs the flow of solubilized substrate into the extremely useful structure "29", referred to herein as a flow regulator or flow directing means. Structure 29 is a piece of non-wettable material which only permits flow of liquid downward, because of the configuration of its pores. As will be seen, the structure is characterized by conical or inverted "V" εhaped poreε. Theεe permit downward flow, but do not permit flow up or acroεε the structure. This flow director 29 iε in fluid contact with the matrix 11, εo the εolubilized/mobilized substrate moves unilaterally into the matrix. In addition to the aforementioned functions, structure 29 may be selected from materials with multiple pore sizes and thus uεed to control the "rate" of fluid flow from component 27 into component 11. Due to uniform placement of poreε in structure 29 a uniform dispersion of fluid entering εtructure 11 is insured. Structure 29 may also be employed as a reagent delivery device by the application and drying of said reagents into the pores of structure 29. Methods of application and drying of reagents will be obvious to those skilled in the art and do not need to be elaborated upon here. The choice of what materials constitute the structures "26" and "27" iε limited only by the requirement that they be absorbent and inert relative to the reagents which contact them. Similarly, structures "28" and "28"', described aε doubleε εtick tape, may be made of any materialε which prevent the flow of liquid. The material choεen for εtructure 29 εhould be one which directε liquid in a εingle direction. A particularly preferred material for εtructure 29 is "Vispore", a material used in the manufacture of disposable diapers and described in U.S. Patent Nos. 3,929,135 and 4,342,314, the discloεureε of which are incorporated by reference herein. The '135 patent deεcribes the structure of the material aε a "tapered capillary", and indeed, one may view the conical or inverted V configuration as such. Hereinafter, "flow director having a tapered capillary pore structure" will refer to the type of material shown in the '135 patent. The entire apparatus deεcribed herein is placed on an inert support 30. This serves merely to give added strength to the apparatus, and may be transparent if reading from the bottom of the strip element is desired, or not. The method of attachment of the strip componentε to the inert support may involve the use of double stick tape, hardened hot melt adhesives, a combination of the two, and/or other materials with suitable adhesive properties, all of which are known to the art. Additional features may be incorporated into the apparatuε. Non-limiting exampleε of theεe include analyte specific antibodieε, εignal inhibitorε, bufferε, and so forth. The apparatus provides a one piece, horizontal flow test device which can be used for all purpoεeε of a particular analyεis test. One can apply sample, and additional active reactants and interpret teεt results all within the same device. A very important feature of the preferred embodiments of the invention is the use of a "true" positive control. As diεcuεεed εupra. in a preferred embodiment of the device both a sample of the analyte of interest and an active reactant, such as an antibody specific for the analyte, can be incorporated such that they will react if the analyte sample is solubilized. Such a control is deεirable becauεe it giveε assurance that active reactant positioned at a different point in the device and deεigned to react with sample analyte remains active. Other advantages of the device will be apparent by reviewing this discloεure as a whole. A particular preferred embodiment of the test stripε described herein involves the use of a procesε by which the receptor material is placed in the matrix. It has been found that the receptor or matrix incorporated molecule of interest can be applied thereto without the use of an adhesive or fixative by applying a charge to the matrix incorporated molecule. The molecule then carries a charge, and interactε with a charge carried by the matrix itεelf. By selecting materials aε the matrix which have a charge oppoεite that of the molecules of interest, or by applying a charge to the matrix opposite that of the charge carried by the molecule, the latter iε incorporated εecurely into the matrix, without the uεe of an adheεive or fixative. A particular advantage of the uεe of the charge interaction to place the receptor material in the matrix iε the ability to control the impregnation or poεitioning of the receptor therein. The material of intereεt, referred to hereafter aε a compoεition of matter, may be in the form of the moleculeε themεelveε, or, in a preferred embodiment, attached to a εolid carrier. In order to apply charge to the composition of matter, various methods, including the positioning of the material in a charged field can be used. It is particularly preferred, however, to apply the charge by treating the compoεition of matter in a εolution which haε a pH that differε from the iεoelectric point ("pi") of the material, i.e., the receptor, of intereεt. When a pH which differε from the pi iε used, the composition of matter accepts a charge therefrom. At a pH below the pi, the composition of matter picks up a positive charge, whereas at a pH above the pi, the received charge is negative. While pi values are generally associated with proteins, they are possessed by all moleculeε including carbohydrateε, lipidε, and the variouε combinationε thereof (glycoproteinε, lipoproteins, glycolipids, etc.) . Thuε, when a term εuch as "protein containing" or "carbohydrate containing" is used hereafter to describe a molecule, it refers to pure species of the molecule as well as the combination molecules. A glycoprotein antigen, for example, iε both a "carbohydrate containing molecule" and a "protein containing molecule". Particular typeε of moleculeε of intereεt and encompaεεed by this invention include all of the standard immunological reagents such as antibodies, be they polyclonal or monoclonal and their fragments and complexes, antigens, including fragments of antigens which are epitopically active, protein A, protein G, biotin, avidin, εtreptavidin, and εo forth. When the composition of matter consists of a receptor and a solid material, the former is bound to the latter. Among the materials which can be used for the solid carrier are synthetic, natural, and "semi-synthetic" materials, which refers to materials which can incorporate both naturally occurring and synthetic material in the carrier. Latex, polystyrene latex, glasε, sepharose, dextran, agarose, εilica, mica, clay, diato ε, and other materialε can be uεed, with latex baεed polymerε being particularly preferred. The εhape of the carrier iε not critical, and it can include, e.g., rod, rhomboidal, and spherical shaped materials, the last of these being especially preferred. While not critical, it iε deεirable that the carrier particleε be of uniform εize, εuch as latex beads having an average diameter of from about 20 nm to about 20 um. Preferred beadε have an average diameter of from about 0.3 um to about 1.0 um, and a particularly preferred embodiment employs beads having an average diameter in the range of from about 0.4 um to about 0.5 um. To monitor the placement of the carrier material on the matrix during any manufacturing procesεeε, it is desirable to use a carrier which is fluorescent or colored, although this is not essential. Aε indicated supra, it is preferred to treat the compositions of matter with a solution having a pH which differs from the pi of the receptor. Generally, the solution may have a pH of from about 2.0 to about 12.0, a pH of from about 3.0 to about 9.0 being specially preferred. The choice of pH for the treating solution will vary, based upon the nature of the molecule, its pi, and other factors. The matrix material, as indicated supra may possesε an inherent charge, or it may be treated to poεεess one. Glaεε fiber, for example, inherently poεsesεes a negative charge, so if a matrix containing glass fibers is used the composition of matter εhould be treated εo that it carrieε a poεitive charge (e.g., treating solution at a pH below the pi) , and the matrix does not have to be treated itself. Other matrix materials which do not possess a charge may be treated to receive one. Matrices can be treated with, e.g., acids or baseε to protonate or deprotonate existing functional groups or by partial hydrolysiε to generate new functional groupε. Other modificationε such as periodate oxidation of aldehydic functions to carboxyl groups, succinylation of amino functional groupε by anhydride treatment or placement of matrices in electric fields may be employed. Non-limiting examples of materials which may be uεed aε matrices include fibrous or bibulous materials, such as filter paper, regenerated cellulose or rag based papers, combinations containing cellulose, cotton, or glass fibers, as well as other fibrous materials. Polyamide and polyacrylamide are examples of fibrous or bibulous synthetics. The various fleeces uεed in analytical testing may also be uεed, aε can filmε, gelatinε, and so forth, all of which are to be included within the scope of thiε invention. Non-fibrouε or non-woven membrane materials may also be employed. Examples of materials which may be used include nylon, nitrocellulose, cellulose acetate, and PVDF. In preparing test matrices, the composition of matter is applied to the matrix, and any solution in which the composition is contained iε then removed. This resultε in an incorporation of the composition in the test matrix. Due to the strength of the interaction of the opposing charges, the composition is bound where it was -placed. Additionally, because like charges repel each other, the problem of clumping associated with solid carriers such as beadε is eliminated. Uεing thiε invention, the solid carrier material is dispersed throughout the matrix, but only where it is disposed. This makes the manufacture of zoned devices, εuch as the three zone devices described supra extremely simple and permits accurate and sensitive evaluation of an analyte being assayed. Test strips made in accordance with the dispersion of the composition of matter described supra can be subjected to further treatment as well, so as to result in analytical devices useful in various types of assays. For example, following the incorporation of a first receptor into the apparatus so that it is immovably incorporated therein, a second receptor which is mobile in the presence of a fluid can be added. If this second receptor iε labeled, the reεulting apparatus is useful in a sandwich type of immunoassay. When a εample containing the analyte of interest is added to the apparatuε, a sandwich of bound receptor, analyte and previously mobile, labeled receptor resultε, after which the label can be determined. Of courεe, the εecond receptor, εuch aε an antibody, can be added from a different εource, i.e., it need not be incorporated in the device. The εkilled artiεan will of course note that test stripε prepared in accordance with this invention can also be adopted for use in competitive and displacement type of aεεayε, with modifications to the test strip in accordance with standard protocols for preparation of teεt εtripε for theεe categories of asεayε. It is alεo poεεible to prepare teεt εtripε in accordance with the proceεs described herein for carrying out multianalyte, or concentration type of assays. By "multianalyte" syεtemε, it is meant that the strip is adapted to identify more than one analyte. This is uεeful, e.g., when the need arises to determine what group(s) of Streptococcus is involved in a patients infection or a patients response to a series of HIV antigens such as p24, gp41 and gpl20. In the same manner the strip apparatus may be configured to perform "TORCH" testing when zone 2 of element 11 has been constructed with the antigens necessary to detect specific antibodies to Toxoplasma. Rubella, Herpes Simplex and Cytomegaloviruε to determine what infection a patient may have. As a "concentration assay" is meant a system where one is to determine whether an analyte of interest is preεent in exceεε of inεufficiency in a εample. In diagnoεing diabeteε, for example, the amount of glucose present in a body fluid sample is the key parameter that is measured. A test εtrip can be set up having a plurality of zones, as shown in Figure 1, but where the color reactions in zones will represent a semiquantitative measure of the analyte "concentration" in the sample. For example, if the first zone contains an amount of receptor just sufficient to react with all of the glucose found in a body fluid sample from a normal individual, the following zones can be used as a monitor for excess or toxic levels, because εignalε εhould not regiεter in the following zones unlesε there is an abnormally large amount of analyte present. Similarly, in situations where, e.g. , a hormone deficiency is suspected, one can calibrate the device so that the first and second zones contain just enough reagent to react with a normal amount of hormone. Using this approach, if no signal, or a weak signal is generated at the second zone, thiε is indicative of an abnormally low amount of the analyte. Test apparatus of the type deεcribed herein are advantageouεly kept in a caεing. Such a casing can not only provide protection to the test strip and safety to the user, but can also facilitate the use of the device in carrying out teεt analysis, as will be εhown from the discusεion that follows. Referring to Figure 3a this showε a top view of a caεing 40, uεed in connection with the teεt device. The top of the casing is an elongated εtructure made of an inert and tough material εuch as polystyrene plastic. A rectangular structure with oppoεing short sideε 41 and 41' and oppoεing longer εideε 42 and 42' iε provided. Referring to 40, from left to right, the top of the casing containε an application port 43, which is diεcussed at greater length infra. This port slopes downward from the opening, and provides a point for application of run buffer to the test strip so as to release any reagents contained therein, aε explained εupra. Moving toward the opposite end of the device a second port 44 is provided, which also slopes downward. This port is poεitioned over the three zoneε of the strip device, i.e., the negative control (21), read (22) , and positive control (23) described εupra. In practice, the sample to be analyzed, aε well aε poεεible other reagentε, are added here. Again, the port εlopeε downward. The angle at which the wallε of the port slope is selected so as to minimize shadowing, which can adversely affect interpretation of results. In the embodiment shown, the arrow 45, "R" 46, and "C" 47 are presented to aid in the use of the device. The arrow indicates where the sample to be analyzed is to be added, and "R" and "C" stand for the "read" or test and "control" or positive zones, respectively. Toward the end of the apparatus the shaded portion is an optional deεign embodiment. A plurality of tabεetε or joining meanε 48 protrude from dorεal εide of the top of the caεing, and are poεitioned to engage correεponding tabεetε (52) in the bottom portion of the casing. Dotted lines 49 and 49' show that the underside of this portion of the casing is recessed to create what is in effect a slightly smaller rectangle within a larger one. The bottom portion of the device, in figure 3b described infra depicts the inner and outer wallε of that portion of the εtructure more clearly, and a parallel configuration iε present in the top portion, which engages the bottom portion. Referring now to Figure 3b, this is an open top view of the bottom portion 50 of the casing. This is made of the same material aε the top portion, and has the same geometrical configuration. A pair of longitudinal barε 51 iε present on the bottom of the casing and, together with a plurality of pairs of tabsets 52 define a guide for positioning of the test εtrip therein and also serve to hold the strip off the bottom of the housing. At least some of these tabεetε combine with parallel tabεetε in the top portion of the casing to form a joined structure when the top and bottom of the casings fit together. The bottom has, around its perimeter an inside wall 53 and an outεide wall 54, which align with equivalent structures 49 and 49' in the top of the casing 40. An important feature of the houεing top is that it is configured so that the four walls of port 44 do not quite touch the teεt εtrip positioned therein. The result is that a small capillary εpace is created which in turn allows port 44 to retain sample and other reagents, and effectively "meters" application thereof to the test strip. Also, because the casing material does not directly contact the test εtrip, there are no uncontrolled or unrecognized effectε on the properties of the test strip itself. A similar type of structure reεults from the interpolation of tabsets protruding from the top and bottom of the casing. When theεe tabsets interact with each other, they effectively seal the enclosed strip element, resulting in formation of at least two reservoirε which retain excess fluid. To elaborate, it will be seen in Figure 3b that hollow spaces 55 and 55' extend over the length of the houεing along the length of the teεt εtrip. These spaceε can hold liquid and, if too much is added at either of ports 43 or 44, this can result in overflow of the strip device. The sealing of casing parts 40 and 50 creates discrete overlfow compartments by interaction of the tabsetε, however, reεulting in retention of the exceεε fluid (εuch as εample and reagents) in the compartment immediately adjacent to the application point until the test strip is ready to absorb it. In effect, this interaction resultε in another metering means, insuring that liquid applied to the strip device enters the strip only at the deεired location. The top and bottom portionε are fitted together and εealed after the actual teεt device or apparatuε iε poεitioned in the bottom portion thereof. The manner of sealing is up to the artisan. Examples of various wayε the sealing can be accomplished are adhesives, application of heat, snap fitting or via εonic energy. It is also conceivable, though not likely, that the casing will be constructed so that the top and bottom portions can be detached and the test strip removed. The actual operation of the invention as deεcribed herein will now be shown via the examples which follow. Example 1 Particles conjugated with an antibody were prepared in accordance with the invention. To do this, fluorescent carboxylated latex having a nominal mean particle diameter of 0.51 microns, were prepared as a 2.5% (w/v) solids εuεpenεion, uεing 0.02% (w/v) εodiu azide/0.02% thimerεol. Anti-εtrep A rabbit polyclonal antibody waε coupled to theεe particleε via carbodiimide linkages. The final product was a 0.5% (w/v) solids suεpension, εtored in 100 mM glycine/50 mM HEPES/150 mM sodium chloride/0.1% (w/v) bovine serum albumin/0.1% (w/v) sodium azide, and 0.01% (w/v) thimerosal. The entire compoεition was at a pH of 7.4. Samples were then prepared for testing by diluting aliquots of the latex to 0.26% solids (w/v) , using 50 mM sodium phosphate/150 mM sodium chloride, at pH 7.2, followed by transfer to 15 ml centrifuge tubes (Corex) , together with buffers of variouε type and pH, aε discussed below. Samples were centrifuged at 9900 rpm (ll,700xg max) for 15 minuteε, and supernatants were aεpirated and discarded. Latex particles were resuspended at 0.27% (w/v) of solids in test buffer. Each suspension was sonicated prior to dilution to 0.005% (w/v) for determination of particle size distribution. The results are summarized in Table 1: Antibody on particles caused aggregation at a pH of 4 , whereas the pH values above and below this yiel d e d particles with very similar distribution means, and which were only slightly greater than underivatized latex (note the coefficient of variation or "CV") . The CV values show that at pH values of 2, 3 and 7. 2 , particles were essentially monodisperse. The variouε εpecieε which make up the polyclonal antibody preparation have isoelectric points ("pis") which vary from 5 to 8. Since the antibody iε being coupled to carboxylated latex the isoelectric point of the latex- antibody conjugate would be somewhat lower than a weighte d average of the isoelectric points of the coupled antibo d y species. Surface charge repulsion is an important factor in maintaining the latex-antibody conjugate in a nonaggregated εtate and it iε likely that a pH 4 a significant proportion of the antibody-latex particles would have insufficient net surface charge to prevent such aggregation. Example 2 The interaction of charged complexes of antibody and latex with a solid support was studied. The proceεε of Example 1 waε followed to attach antibodieε to latex particles. Additional samples were prepared by diluting aliquots of underivatized latex to 0.5% (w/v) solids with the same dilution buffer described in Example 1. Separate aliquots of the underivatized latex and antibody-latex conjugates were transferred to 2 ml microcentrifuge tubes together with the various buffers of Table 1. Samples were centrifuged at 14,000 rpm (16,000xg max) for five minutes. Supernatants were aspirated and discarded, after which the resulting latex pellets were resuspended at 0.2% (w/v) solids in the test buffer uεed previouεly. Three aliquots (25 ul each) of each test sample were than directly pipetted onto the more porous side of glass microfiber paper. Interaction waε observed by fluorescence under long wave UV light. Fluorescent spots were photographed using UV transillumination, and a Polaroid camera. Figure 4 shows these resultε. Latex εa ples were added to the glass microfiber paper in 50 mM sodium phosphate (pH 2, 4, 6, 8, 10 and 12) with antibody coupled to the latex (samples 2, 4, 6, 8, 10 and 12) or without antibody coupled to the latex (sampleε 2R, 6R, 8R, 10R and 12R) . Additional samples in 50 mM acetic acid (pH 3) with antibody coupled to the latex (sample HAC- 3) and without antibody coupled to the latex (HACR-3) were alεo evaluated. The figure εhows that when antibody is preεent on the latex, the interaction between latex and glass microfiber paper increaseε dramatically - i.e., εpot diameter decreases, showing much lesε diffusion/dispersion on the paper, and "tighter" positioning. This permits the manufacture of test strips with the receptor carrying particles in precise, chosen positions. The data show that the enhanced interaction varieε with pH. When the pH of the teεt buffer iε lower than antibody pi valueε (i.e., pH 2-4), the degree of dispersion is lessened. Example 3 Further studieε were carried out which confirmed one of the concluεionε reached from the experimentε of Example 2 - that the presence of a charged receptor on the particles helped in reducing dispersion. Rabbit anti-strep A antibodies, as described supra, were correct together with the glasε microfiber paper of the prior exampleε. Conjugates of anti-strep A antibodies and peroxidaεe (POD) were prepared by generally following Nakane et al., J. Hiεt & Cyt. 22(12) : 1084-1091 (1974) . In addition, Group A εtreptococcal carbohydrate antigen waε prepared, generally following Kholy et al., Appl. Microbiol. 28(5) : 836-839 (1974) . Deviceε in accordance with Figure 2 were prepared. The antibody deεcribed εupra waε diluted to either 250 ug/ml or 600 ug/mL in 50 mM εodiu phoεphate, at pHε of 2, 4, 6, 8, 10 or 12, or in 50 mM acetic acid, at pH 3. A 12 ul quantity of antibody at both concentrationε and at the various pHs was applied onto glass microfiber teεt regionε to provide evaluation materialε. Each teεt εtrip waε prepared in duplicate for both concentrations, at all pHs liεted. The εtripε were dried at 37°C for one hour. In the tests, a 270 ul volume of neutral pH buffer was added to each of the duplicate test strip's glass microfiber paper, while the second of the strips received 2 ng/ml Group A streptococcal carbohydrate antigen. Thiε antigen had been prepared following Kholy et al., App. Microbiol. 28(5) : 836-839 (1974) . Following application of either control or antigen, 35 ul volumeε of 4 U/ml peroxidaεe labeled rabbit anti-εtrep A antibody conjugates were applied, and incubated for one minute. After this, 1 ml samples of sodium perborate tetrahydrate in PBS were applied to the spongeε of the εtripε. The εtrips were observed visually, after 15 minuteε for color reactionε to indicate binding of the anti-strep A antibodies to the paper. Figure 5 shows typical resultε, demonεtrating what iε referred to aε the pH effect. At pH 4, a color reaction waε obεerved, but not at pH 10. Generally, when the pH value waε below that of a typical pi value for antibodieε (range of 5.6 to 7.7) , color reactions were observed in both phosphate and acetate buffers. As pHs increased from 6 to 10, the color reaction gradually diminished. No color reaction was obεerved in the absence of Group A streptococcal carbohydrate antigen, which εuggests specificity and that the binding of antibody to glass microfiber paper in the manner described herein does not prevent interaction with antigen. Thus, strips prepared in the manner described herein can be used in qualitative immunoassay deviceε. Example 4 Mobility of underivatized fluoreεcent latex waε compared to the mobility of latex-antibody conjugates. Devices and reagents were prepared as described supra, as was the protocol for reagent application. Test buffer for re-suεpenεion of latex and latex-antibody conjugates was either 50 mM sodium phoεphate, at pH 2 or at pH 12, or 50 mM acetic acid, at pH 3. Interaction of latex with the paper εtrip waε obεerved via ultraviolet light fluorescence before and after strip development. Exemplary photographs are preεented in Figure 6. Figure 6, it will be seen, supportε the contention that when antibody is present in the latex, it plays an esεential role in the interaction with the teεt support (e.g., glasε microfiber paper) . It εhould be noted, e.g., that there iε a leεε diεtinct band for raw latex prior to strip development, and a reduction in band fluoreεcence for raw latex after the εtrip was developed. Example 5 The foregoing examples showed the feaεibility of uεing antibodieε in the invention described herein. Other proteins are also usable, as is now shown. Recombinant, HIV-1 proteins containing immunodominant regions for the p24 and gp41 molecules were obtained, as waε human IgG from an HIV-1 poεitive patient which exhibited high anti-gp41 reactivity. Mouse monoclonal anti-HIV-1 p24 antibodieε were alεo secured, as were goat anti-human IgG and goat anti-mouse IgG peroxidase conjugates. The p24 protein was supplied in 0.1M sodium phosphate buffer at pH 8.5, and containing 1% SDS (w/v) . This waε diluted from 23.9 mg/ml to 4.0 mg/ml, uεing 0.01 M sodium phosphate buffer at pH 7.5. Buffer was exchanged against sodium phoεphate buffer, using a 10 KDa Centricon Unit. Similarly, gp41 recombinant protein was exchanged from 0.1M sodium phosphate buffer at pH 7.5, where the buffer contained 0.1% (w/v) SDS and 5 mM EDTA. Test samples of the proteins were diluted to 1 mg/ml in 50 ml sodium phoεphate, at pHε of 2 , 4, 6, 8, 10 or 12, or in 50 ml acetic acid, at pH 3. Application protocolε were exactly as described for the anti-Strep A antibodieε aε diεcuεεed in Example 3. Again, following Example 3, 270 ul volumeε 1:100 (v/v) dilution of murine monoclonal anti-HIV p24 antibodieε were applied to one of the duplicate εtrips, while equivalent volumes of HIV negative εerum samples were added as controls to the other strip. This was followed by addition of 35 ul aliquots of goat anti-mouεe IgG peoxidaεe (1:200 (v/v) dilution) and goat anti-human IgG peroxidaεe conjugates (0.1 U/ml) to the strips, and then 1 ml of a PBS solution containing sodium perborate tetrahydrate. Again, as in Example 3, viεual color waε obεerved, thiε time after 10 minuteε. Formation of color indicateε either the preεence of p24: mouεe IgG complexeε, or p24: human IgG complexes. Figure 7 εhowε theεe reεultε. The "firεt" strip of each sample, which used the murine samples, showed that where protein impregnation took place at low pH (2 and 3) . there was extremely tight binding to the filter paper. As pH levels increased, mobility increased. While negative samples did εhow some non-specific binding, all samples were far lesε reactive than the positive stripε. Example 6 The protocol uεed in Example 5 waε uεed to teεt gp41, the only differences being that the positive control was purified human anti-HIV gp41 IgG (62 ug/ml) , and goat anti- human IgG peroxidaεe conjugate (0.1 U/ml) waε used on both stripε. The photograph of Figure 8 εhowε, yet again, that there waε a correlation between mobility and increaεed pH. Example 7 Strip elements as deεcribed herein and as shown in Figure 2, were used for detection of Group A streptococci. Matrix 20 waε first prepared by cutting a piece of Whatman glasε fiber paper with polyvinyl alcohol fiber into a εtrip 2.8 cm long and 0.6 cm wide. The firεt portion of thiε strip was impregnated with 6-12 ul of a 0.1% (w/v) solidε εuspension of 0.4 - 0.5 um polyεtyrene latex having nonimmune rabbit IgG coupled to its surface. The middle portion of this strip was impregnated with a εimilar εuεpension of latex coupled to affinity-purified rabbit- anti-Group A Strep IgG. The end portion of the matrix was impregnated with both a conjugate of rabbit-anti-Group A Strep IgG coupled to latex and 6 ul of a solution of purified Group A Strep carbohydrate antigen, at a concentration of 60-80 ng/ml. The matrix was dried at 35°C for approximately 20 minutes. Thiε produced a complete matrix having a linear array of solid phase zones representing a true negative control "21", a test result zone "22" and a true positive control "23". One end of the matrix underlapped 2 mm of a 6.5 cm long and 0.6 cm wide εtrip of 320 paper "24", impregnated at waste "25" with approximately 60 ul of a 100 mg/ml aqueous solution of sodium azide. The opposite end of the matrix underlapped 4 mm of 1.2 cm long and 0.6 cm wide strip of X6212 Vispore. A 1.2 cm long and 0.6 cm wide strip of double stick adhesive was placed atop the Vispore. A strip of paper "27", measuring 1.5 cm long and 0.6 cm wide was positioned atop the double stick adhesive. The εtrip of paper had been impregnated with approximately 50 ug of a chromogenic εubεtrate for peroxidaεe, i.e., 4-methoxy-l-naphthol, and dried for 15 minuteε at 40°C. The paper overlapped the matrix component by 2 mm and thus establiεhed direct fluid contact with the matrix through the porous Vispore. A 1 cm long and 0.6 cm wide strip of double stick adhesive "28" was placed atop the paper 3. The adheεive waε poεitioned in a manner which created a 0.5 cm "window" on the top εurface end of the paper 27 at a position furthest from the matrix component. Finally, a sponge "26" measuring 4 cm long and 0.6 cm wide was fixed to the top of component 28. All strip componentε overlapped aε indicated to form a continuouε εtrip and were mounted on a 13 cm long and 0.6 cm wide piece of polyeεter carrier foil uεing hotmelt and/or double εtick adheεiveε. Stripε conεtructed aε deεcribed were uεed for the detection of Group A εtreptococci. Swabε, εpiked with 0, 2.5 x 10 , 5 x lθ 4 and l x lθ 5 Group A εtreptococcal colony- forming unitε (CFUε) were placed in εmall glaεε teεt tubeε and εubjected to a εtandard two minute micronitrouε acid extraction following El-Kholy et al., supra to release the group specific carbohydrate antigen from the cell wall of the intact streptococci. Following extraction, the nitrous acid extract was neutralized with a weak baεe and 250 to 300 ul of the neutralized extract waε applied in a dropwise fashion to the matrix component of the strip element between points 21 and 22. Next, 30-35 ul of a 5 unit/ml peroxidase labeled rabbit anti-strep A conjugate preparation in a buffer waε applied to the εame location of the matrix. In a final step, 1.2 ml of a phosphate buffered saline εolution containing εodium perborate tetrahydrate was applied to component 26 of the strip element. All εtripε to which extracted group A εtreptococcal CFUε were added exhibited blue stripes at both of positionε 22 and 23 of the εtrip matrix component. Stripε run with extractε not containing group A εtreptococcal CFUε exhibited a blue line at position 23 only. The blue coloration on the matrix was indicative of the action of peroxidase on the chromogenic substrate 4- methoxy-1-naphthol in the presence of hydrogen peroxide at the zones depicted by 22 and 23. The irreversible inhibition of peroxidase by interaction with the sodium azide in waste zone 11 of the absorptive reservoir 24 prevented subεtantial color development in this reservoir. This helped to preserve the stability of the teεt results on the matrix component by eliminating the possibility of back diffusion of color onto the matrix during the evaporative drying of the εtrip element. Example 8 To test the flexibility of the strip device for use with alternate enzyme/substrate signal generating systems, strips were constructed and assayed in a fashion identical to that deεcribed in Example 7 with the following exceptionε: component 27 was impregnated with approximately 50 ul of a solution of 5-bromo-chloro-3- indolyl phosphate (1-2 mg/ml) ("BCIP") and nitrobluetetrazoliu (0.25-0.5 mg/mL) (NBT) , no signal inhibitor was incorporated into component 11, and the assay was performed using 40-50 ul of a 5-10 unit/ml alkaline phosphatase labeled rabbit anti-strep A conjugate and 50 mM 2-amino-2 methyl-i-propanol containing wash buffer. All strips to which extracted group A εtreptococcal CFUε were added exhibited purple bandε at both zoneε 22 and 23 of the strip matrix component. Strips run with extracts not containing group A εtreptococcal CFUs exhibited a purple line at zone 23 only. Example 9 To demonstrate the utility of the strip device with a non enzymatic signal generating system, a gold labelled rabbit anti-Group A εtrep IgG conjugate waε prepared with 30 nm Aurobeads (Janεεen) . The procedures and buffer systems used for preparation of the conjugate were those recommended by the manufacturer for the labeling of 30 nm particles with polyclonal antibody. An antibody concentration of 5-10 ug/ml of gold εol waε uεed for labeling. The εtrip element was constructed in a fashion identical to that described in Example 7 with the exception that components 28 and 27 were not incorporated into the strip and no signal inhibitor as used in τhe waste zone 25 of adsorptive reservoir 24. To evaluate the strips, 250- 300 ul of a neutralized nitrous acid extract containing either zero or 1 x 10 5 streptococcal CFUs was applied to the matrix component between zones 21 and 23. This step was followed by the application of 50 ul of a suεpenεion of gold labeled antibody, adjusted to an absorbance at 520 nm of 5.0 to 7.0, to the same region of the matrix. In the final step of the assay, 1.2 ml of a phosphate-buffered saline wash solution was added to component 26. Strips to which neutralized extract containing group A streptococcal CFUε waε added exhibited red lineε in zoneε 22 and 23. Strips receiving extract void of Group A streptococcal CFUs exhibited a red line in zone 23 only. Example 10 To demonstrate the utility of the εtrip device with an "on board" signal generating system, stripε were constructed in a fashion identical to that described in Example 1 with the exception that component 27 contained the gold labeled antibody uεed in Example 9 in dry form. Stripε were evaluated by applying neutralized nitrouε acid extractε with or without εtreptococcal CFRε to the matrix component as described in Example 9. Following application of sample to the matrix, 1.2 ml of phosphate buffered saline wash εolution waε added to component 27. The gold labeled rabbit anti-strep A IgG released from component pad 27 bound to group A antigen captured in zones 22 and 23 on strips exposed to sample containing group A streptococcal CFUs. Strips exposed to extracts void of group A streptococcal CFUs exhibited a red line at zone 23 only. Example ll To demonstrate the uεe of the εtrip device in a dipstick format, strips were prepared as described in Example 1 with the exception that component 26 waε not incorporated in the strip element. Sample and conjugate application was performed as deεcribed in Example 7. In the final εtep of the aεsay, strips were placed into 12 x 75 mm test tubes containing 500 ul of phosphate-buffered saline with a peroxide generating compound such that component 3 was brought into contact with the wash solution. Stripε expoεed to εample containing group A streptococci exhibited blue lines at zones 22 and 23. Strips expoεed to sample void of group A streptococci exhibited a line at zone 9 only. Example 12 To demonstrate the use of the strip device for the detection of other analyteε, εtripε were constructed and asεayed in a faεhion similar to that described in Example 7 with the following exceptions: component 20 was impregnated with 12 ul of a 0.1% (w/v) solids suspension of 0.4 - 0.5 μm polystyrene latex coated with p24 or gp41 (HIV-1 antigens) recombinant peptides or a 1 mg/ml solution of the individual purified proteins and no negative or poεitive control lineε (zoneε 21 and 23) were included in 20. Additional differenceε included: (1) no signal inhibitor incorporated into the waste zone 11 of component 10, (2) human serum HIV-1 positive and negative samples (1:100 v/v) dilutions) or specific murine monoclonal antibodies (e.g., NEN mouse, anti-HIV-1 p24) were used as controls and (3) goat-anti-human IgG and anti-mouse IgG- peroxidaεe conjugateε were uεed aε εignal generating reagentε. Serum samples containing antibody to either p24 or gp41 when utilized with this device generated a visible line (22) of the type described in Example 7 whereaε no εignal waε generated with negative serum samples. Example 13 To demonstrate the use of the strip device for the detection of other analytes, strips were constructed and asεayed in a faεhion similar to that described in Example 7 with the following exceptions: component 20 was impregnated with 12 μl of 0.2% (w/v) solids suεpenεion of 0.4 - 0.5 μm polyεtyrene latex coated with mouse monoclonal anti-βhCG antibody (zone 22) and a positive control (zone 23) consisting of sheep polyclonal anti-mouse IgG antibody coated on the above mentioned latex. In thoεe preliminary experimentε no negative control (zone 21) waε utilized. Additional differences included: (1) no signal inhibitor was incorporated into component 24, (2) hCG samples (0, 50 and 500 mlU/ml) in both PBS and human urine were used as controls and (3) mouse monoclonal anti-holo hCG-HRP conjugate was used as the signal generating reagent. An anti-holo hCG antibody iε one which binds to an epitope created by the α and β chains of hCG, and only bindε to such an epitope. Differences in the aεεay format were volume related; that is, 150 μl of sample, 50 μl of mAb anti-holo hCG-HRP (12 U/ml) and 850 μl of run buffer. Similar resultε were obεerved with εtripε having the mAb anti-holo hCG-POD conjugate dried in component 20 prior to teεt zoneε 22 and 23, which eliminated the need for manual liquid conjugate addition. Urine samples containing hCG when utilized in this device generated two visible lines (zones 22 and 23) , one being the test region the other being the poεitive control. Urine εampleε devoid of hCG exhibited a single visible line (zone 23) in the positive control region. Example 14 A test strip waε prepared and uεed to analyze hCG in urine. The εtrip waε identical to Example 15, except mAb anti-holo hCG was conjugated to alkaline phosphatase; component 27 was impregnated with BCIP/NBT (0.5 mg/ml of each in methanol) and an alkaline phosphataεe run buffer was used. Similar results were obεerved with εtripε having the mAb anti-holo hCG alkaline phosphatase conjugate dried in component 20 prior to test zones 22 and 23 which again eliminate the need for manual liquid conjugate addition. Urine samples containing hCG when utilized in thiε device generated two viεible lineε (zoneε 22 and 23) , one being the teεt region the other being the positive control. Urine samples devoid of hCG exhibited a single visible line (zone 9) in the positive control region. The foregoing examples thus show the featureε of the invention. Theεe featureε include, e.g., a process useful for making a test element uεeful in analytical proceεses, εuch aε diagnosis of various parameterε. This manufacturing procesε, in itε broadest embodiment, requires applying a charge to an analyte specific receptor, and then applying thiε compoεition of matter to a teεt element carrying an oppoεite charge. The interaction of chargeε immobilizeε the composition of matter sufficiently εo that adheεiveε are not neceεεary to render the resulting device useful. The composition of matter, as the phrase iε used herein may refer to something aε εimple as a sample of analyte specific receptor. Some potential analyte specific receptors are discussed infra. In a preferred embodiment of thiε aεpect of the invention, the compoεition of matter alεo containε a carrier, to which the analyte specific receptor is bound or to which it adheres. Again, exampleε of carriers are given infra. In a particular preferred embodiment, the composition of matter iε treated to impart a charge thereto by contacting with a solution having a pH other than the isoelectric point ("pi") of the analyte specific receptors making up or contained in the compoεition of matter. The manner in which thiε type of contact is carried out, including the determination of pi of the analyte specific receptors, is well known to the art and doeε not require elaboration herein. Aε indicated, the composition of matter is applied to a test element which carries a charge. It is to be noted that some of the materials generally used for test elements, including papers, carry a charge. When such materials are uεed, no further treatment iε necessary to ensure immobilization of the composition of matter to the test element. When the test element does not carry a charge, however, it can be treated to carry one which is opposite to that carried by the compoεition of matter. There are many standard ways of doing thiε, for example, by treating a cellulose containing test element with periodate, exposing a nylon test element to acidic condition or by subjecting the material to an electric field. The nature of the analyte specific receptor may vary. Common receptorε include antibodieε, both polyclonal and monoclonal, as well as binding fragments of these, and oligovalent or "polymerized" antibodies. The receptors may be other proteins εuch aε protein A or protein G, and εince the receptor may alεo be an antigen when the aεsay determineε antibodieε (note the HIV assayε, εupra) , any binding protein may serve as an analyte specific receptor. Similarly, receptors such aε a lectin may contain carbohydrate, lipid or nucleic acid molecules, as well aε the aforementioned proteins. Biotin and avidin/streptavidin as well as derivatives of these are encompasεed herein, as are receptors which have been treated in a manner which does not change their ability to bind analyte. Examples of such modifications need not be given here, as the art is presumably familiar with, e.g., εuccinylation of proteinε to render theεe more amendable to solid phase binding. The analyte specific receptors are chosen, of courεe, on the baεiε of the aim of the aεεay. Typical tests include, e.g., aεεayε for etiological agentε for infectiouε diseases, including, but not limited to, the sexually transmissible diseases ("STD") . The receptor is thereby chosen to bind an epitope of the cauεative agent. In addition to the εpecific microorganiεms mentioned supra, Chlamydia. Rubella, Cytomegalovirus, Toxoplasma. Neisεeria. Herpes, and Human Immunodeficiency Virus are some of the organisms which can be asεayed. When carriers are used in connection with the receptors described herein, the "carrier" may be any of the materials associated with the diagnostic apparatus. These include, but are not limited to carriers of a specific shape (e.g., a bead or sphere) , or of specific synthetic or natural materialε, such as latex, glasε, cross-linked carbohydrates, agarose, polyεtyrene, dextran, mica, and diatomaceouε earth. Theεe carrierε may be εolid or porouε. Especially preferred are carriers which are of a uniform size, and are from about 1.0 nm to about 20 um in diameter. Eεpecially preferred are 0.3 to 1.0 um particleε, thoεe of 0.4 to 0.5 um diameter being particularly preferred. After the particleε have been applied to the teεt carrier as indicated, the resulting material may be used to manufacture the diagnostic apparatus. Such apparatus are another aspect of the invention, including multizoned materials. The most salient feature of the apparatus of the invention includes the presence of three distinct zones, each of which compriseε abεorptive material. Theεe zones are preεented in a way εo that a fluid or sample being analyzed may move through each of these. The first zone iε characterized by containing a non-reactive immobilized material, such as non-binding IgG. These materials are uεeful in allowing the uεer to judge the integrity of the particular device being used. The second zone is manufactured εo aε to comprise an analyte specific receptor, which may, but need not be, attached to the absorptive material in the manner described supra. The third zone contains both analyte receptor and analyte to be determined. This combination ensures that, if the device is functional, binding will take place in the third zone. The analyte in the third zone may, but need not be dissolvable in sample being tested. The presence of immobilized reactant ensures that the analyte contained therein will be immobilized, whether it is dissolvable or, e.g., present on carriers such aε thoεe deεcribed supra. It is indicated, supra, that the analyte specific receptor of the apparatus of the invention may be any of the types of receptors discusεed εupra. Similarly, these receptors may be positioned on any of the carriers described supra. The support used to make the test carrierε aε well as the apparatus may be fibrous (e.g., it may contain glasε fibers) , bibulous (e.g., containing absorptive paper or cellulose) , and may also be membranous, such as a gel, film, web, etc. There are many different embodiments of the apparatus and proceεεes of the invention described herein, all of which are useful to the skilled artisan. For example, one can apply basic principles of diagnostic analysiε to make variantε of the devices described herein. As has been pointed out, the immobilization method described leadε to the poεitioning of an analyte specific receptor. A second receptor may also be incorporated into the test carrier or apparatus. In εuch a situation, the second receptor may bind with either the anaiyte of interest, thereby creating a sandwich structure of first receptor - analyte - second receptor, or it may bind directly to the firεt receptor, thereby competing with analyte for binding. In either of theεe embodiments, it is deεirable that the second receptor carry a label which provides a detectable signal. The label chosen may be an enzyme, a gold sol, a dye sol, a colored particle, a fluorescer, a chemilumineεcer, or a radiolabel. When an enzyme, εuch aε β galactoεidaεe, peroxidase, alkaline, phosphataεe, ureaεe, or glucose oxidase iε uεed, the teεt carrier may alεo contain a εubεtance which reacts with the enzyme to provide a signal, generally but not exclusively a colored one. The listed enzymes must be taken as examples of the enzymes which may be used. The roster is not comprehensive. It is well recognized that in many εituations, including, e.g., diagnosis of STDs, it is desirable to analyze a sample for more than one analyte at the same time. The invention provides a method for making devices useful for such polyanalyte analyεis, wherein a plurality of different compositions of matter are used, these being poεitioned at different areaε of a test element. Various configurations are also available for the construction of test apparatuε in accordance with the invention. The description of the multi-zoned devices of the invention provided supra explains how all three zones contain immobilized reactant. Aε the reactantε in both the second and third zoneε muεt bind the analyte of intereεt, it iε εometimes desirable, although not necesεary, that theεe be identical. For example, in a thyroxin aεεay, one of the zones 2 and 3 may contain immobilized anti-thyroxin antibodies, and the other immobilized thyroxin binding protein. Both zones may also contain one of theεe. Similarly, in assaying for HIV antibodies, two different peptides may be used in the two zones, or the εame peptide may be used in both. Also, as the examples show, there are antibodies which bind only to epitopes created when two single chains combine to form a dimer, and antibodies which are εpecific to only one chain. This type of antibody diversity may also be exploited in the invention. The first zone, as indicated, contains an active immobilized reactant. The choice of material used herein may vary, although it is preferred to use an inactive form of the immobilized reactant in one or both of the second and third zones. Inactivation may be secured by treating with heat or various chemical agents, e.g. In constructing the apparatuε of the invention, it may be deεirable to configure the zones εuch that the flow of a εample iε controlled. This can be accomplished, e.g., by having two contiguous zones positioned so that the direction of fluid flow in one iε perpendicular to flow in the other. While the deviceε diεcloεed herein require three zoneε, they are not limited to only three. Indeed, it may be preferred to add a fourth zone, poεitioned downεtream of the third zone. The practical advantageε of the fourth zone include the ability to abεorb exceεs liquid in the device. Alεo, the fourth zone, as it is positioned away from the sites of immobilizing reactions, may contain various materials that allow the user to determine whether the particular test strip is still functional, aε well as how far the reaction iε proceeding. Among the materials which can be incorporated into the fourth zone are substanceε which change color in the preεence of a liquid, pH indicators which change color when εubjected to pH stresεes, and, in a particularly uεeful embodiment, εignal inhibitorε. Thiε embodiment iε uεeful becauεe frequently, excess labeled reactant or colored products of a reaction will flow into the fourth zone, and then "backwash" into one or more reaction zones. The use of an inhibitor helps to prevent this type of situation from happening. A fifth zone may also be used, either together with the fourth zone aε described, or with only the first through third zones. This fifth zone is positioned upstream of the first zone, and will contain reaction chemistry, such as a labeled receptor which takes part in the analyte reaction. Thiε labeled receptor iε released and flows into the various zones and reacts in the manner described supra. An adεorptive means will be used in connection with the fifth zone, and is in fluid contact with it, as is the fitth zone with the first zone. Due to the contact of first and fifth zones, it may be desirable to inhibit or to regulate the flow of fluid, and in such a case an inhibition means may be incorporated, so as to direct liquid into the fifth zone and away from said firεt zone. The fluid then moves from the fifth zone into said first zone, but not directly into the first zone. The regulating means described herein is preferably one which directs fluid to move a vertical direction. Preferably, when all of the zones desired are configured in the manner desired, they are placed on an inert support of the type generally used in diagnostic test stripε. In particular, it iε preferred that the first, second and third zones be placed on an inert support. It has been mentioned, supra, that it is posεible to incorporate a εecond receptor into the apparatus of this invention. Incorporation into the device per se is not necessary, however, as the second receptor may be provided in a separate portion external to the actual apparatus, but as part of a kit. Such a kit may also include a separate portion of a run buffer, i.e., a material added directly to the device which iε generally inert and which helps with the migration of various components of the assay through the device. Other embodiments of the invention will be clear to the skilled artisan and need not be set forth here. It will be understood that the specification and examples are illustrative but not limitative of the present invention and that other embodiments within the spirit and scope of the invention will suggest themselves to those skilled in the art.

Claims: We claim: 1. Proceεε for preparing a teεt element uεeful in analysis of a sample, comprising: (i) treating a composition of matter which comprises an analyte specific receptor so as to impart a charge thereto, and (ii) applying said charged composition of matter to an area of said test element which carries a charge opposite to that of said charged composition of matter so as to bind said charged compoεition of matter thereon. 2. Proceεε of claim 1, wherein εaid compoεition of matter further comprises a carrier to which said analyte specific receptor iε bound. 3. Process of claim 1, wherein said treating comprises contacting said compoεition of matter with a εolution which haε a pH which iε different from the isoelectric point of said analyte specific receptor. 4. Procesε of claim 1, further comprising treating said test element to impart a change thereto opposite to said charged composition of matter. 5. Proceεε of claim 4, comprising treating said test element by oxidation with periodate. 6. Proceεε of claim 4, comprising treating εaid test element by placing it in an electric field. 7. Process of claim 1, wherein said analyte specific receptor compriseε a protein containing molecule. 8. Proceεε of claim 7, wherein εaid protein containing molecule iε εuccinylated. 9. Procesε of claim 1, wherein said analyte specific receptor comprises a carbohydrate containing molecule. 10. Procesε of claim 1, wherein said analyte specific receptor comprises a lipid containing molecule. 11. Proceεε of claim 1, wherein εaid analyte specific receptor comprises an antibody or bindable fragment thereof. 12. Process of claim 11, wherein said antibody or bindable fragment thereof specifically binds to an epitope characteristic of an organism asεociated with an infectiouε disease. 13. Procesε of claim 12, wherein εaid infectiouε diεeaεe aεεociated organiεm iε Streptococcus, Chlamydia. Rubella, Cytomegalovirus, Toxoplasma, Neiserria, Herpes or Human Immunodeficiency Virus. 14. Procesε of claim 1, wherein εaid analyte εpecific receptor compriεes an antigen or epitopically active fragment thereof. 15. Procesε of claim 14, wherein εaid antigen or epitopically active fragment thereof deriveε from an infectiouε organism. 16. Process of claim 11, wherein said infectious diseaεe associated organiεm is Streptococcus, Chlamydia. Rubella. Cytomegalovirus, Toxoplasma. Neisεeria, Herpeε or Human Immunodeficiency Viruε. 17. Proceεε of claim 1, wherein εaid analyte εpecific receptor compriεeε a lectin, εtreptavidin, avidin, protein A or protein G. 18. Process of claim 2, wherein said carrier is porous. 19. Proceεε of claim 2, wherein εaid carrier is solid. 20. Procesε of claim 2, wherein said carrier is a bead or sphere. 21. Proceεε of claim 2, wherein εaid carrier compriεeε εynthetic material. 22. Proceεε of claim 2, wherein εaid carrier comprises a natural material. 23. Procesε of claim 2, wherein εaid carrier compriεeε latex, glaεε, a croεε-linked carbohydrate, agarose, polystyrene, dextran, mica or diatomaceous earth. 24. Procesε of claim 2, wherein εaid carrier comprises particleε of uniform size. 25. Process of claim 24, wherein said particleε are from 1.0 nm to 20 μm in diameter. 26. Process of claim 25, wherein said particleε are from 0.3 to 1.0 μm in diameter. 27. Process of claim 26, wherein said particles are from .4 to .5 μm in diameter. 28. Process of claim 1, wherein said area of said test element compriseε fibrous material. 29. Procesε of claim 28, wherein said fibrous material comprises glasε fiberε. 30. Proceεε of claim 1, wherein εaid area of said test element comprises bibulous material. 31. Procesε of claim 30, wherein said bibulous material comprises cellulose. 32. Process of claim 1, wherein said area of εaid teεt element iε a membrane. 33. Proceεε of claim 1, further compriεing incorporating a second receptor into said test element, wherein said second receptor specifically binds to said analyte or to said first receptor. 34. Proceεε of claim 33, wherein εaid second receptor carries a label which giveε a detectable εignal. 35. Proceεs of claim 34, further comprising incorporating a subεtance which reacts with said label to provide said detectable εignal. 36. Proceεs of claim 33, wherein said second receptor is an antibody or bindable fragment thereof. 37. Process of claim 33, wherein said second receptor is an antigen or epitopically active fragment thereof. 38. Proceεε of claim 29, wherein εaid label iε an enzyme, a gold εol, a dye sol, a colored particle, fluorescer, chemiluminiscer, or radiolabel. 39. Proceεs of claim 38, wherein said enzyme is β- galacto-sidase, peroxidaεe, alkaline phoεphataεe, urease or glucoεe oxidase. 40. Procesε of claim 1, further comprising treating a plurality of compositions of matter, each of which containε a different analyte εpecific receptor so as to impart a charge to each, and applying each of said compositions of matter to an area of εaid teεt element. 41. Proceεs of claim 40, wherein each of said compositionε of matter iε applied to a separate area of said test element.

Inventors: BUCK HARVEY B, KINCH MICHAEL J, LEDDEN DAVID J, MOORMAN DAVID R, BUCK, HARVEY, B., KINCH, MICHAEL, J., LEDDEN, DAVID, J., MOORMAN, DAVID, R.
Applicants: BOEHRINGER MANNHEIM CORP, BOEHRINGER MANNHEIM CORPORATION
Application year: 1993
Main classification: G01N33
IPC codes: G01N21, G01N33